FLSM
ALPN

Frazier Life Sciences Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Frazier Life Sciences Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,131,008
Closed -$124M – 57
2024
Q1 		$124M Hold
3,131,008
– – 5.24% 5
2023
Q4 		$59.7M Buy
3,131,008
+145,251
+5% +$2.02M 3.19% 10
2023
Q3 		$34.2M Hold
2,985,757
– – 2.27% 12
2023
Q2 		$30.7M Hold
2,985,757
– – 1.83% 14
2023
Q1 		$23.1M Hold
2,985,757
– – 1.67% 14
2022
Q4 		$21.9M Hold
2,985,757
– – 1.36% 19
2022
Q3 		$21.5M Hold
2,985,757
– – 1.66% 18
2022
Q2 		$25.4M Sell
2,985,757
-1,200,000
-29% -$10.3M 2.4% 13
2022
Q1 		$37.5M Buy
+4,185,757
New +$36.2M 3.2% 11

Frazier Life Sciences Management's ALPN Position: Q2 2024 in Review

Frazier Life Sciences Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 3,131,008 shares — an estimated $124M sold.

Frazier Life Sciences Management first reported a position in ALPN in Q1 2022 and held it in 9 quarters. The position peaked at $124M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Frazier Life Sciences Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Frazier Life Sciences Management sold 3,131,008 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $124M.
  • Frazier Life Sciences Management first reported a position in Alpine Immune Sciences Inc in Q1 2022 and held it in 9 quarters.
  • Frazier Life Sciences Management's Alpine Immune Sciences Inc position peaked at $124M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Frazier Life Sciences Management's 13F filing for Q2 2024, filed 15 Aug 2024.